We are excited to announce that Richmond will be presenting at the upcoming Pulse Virtual Event aimed at GPs, focusing on key areas including respiratory, cardiovascular disease (CVD), diabetes, and nutrition.

Event Details:

  • Date: Wednesday 18th September
  • Time: 13:40 - 14:25
  • Topic: Transforming patient care: your role in clinical trials for patients with CKD, CVD, and hyperlipidaemia

Our lead research physicians, Dr Priscilla Ochuba and Dr Amir Majid, will deliver an insightful session on the critical role GPs can play in improving clinical trial enrolment, especially in therapeutic areas with limited patient populations.

Key Highlights of the Session:

  • Exploring how GPs can enhance patient referral processes, helping to ensure diverse and timely participation in clinical trials.
  • Focusing on clinical trials in chronic kidney disease (CKD), cardiovascular disease (CVD), and hyperlipidaemia as case studies, showcasing advancements in treatment options and enrolment strategies.
  • Richmond Pharmacology's commitment to collaborating with GPs to optimise patient recruitment, ensuring the highest standards of care and research quality.

Don’t miss out on this opportunity to learn how GPs can significantly impact clinical research and patient care. 

For the full agenda and to register: Virtual event for GPs - Respiratory, CVD, Diabetes, Nutrition (pulse365.uk) 


#Pulsevirtualevent #Pulse365

Latest news

Richmond Pharmacology Appoints Dr Daniel Chapple as Commercial Director

July 13, 2026
Richmond Pharmacology, the London-based contract research organisation and global leader in early phase clinical trials, announces the appointment of Dr Daniel Chapple PhD FCIM as Commercial Director.
Read more

Upcoming Event

ESC Congress 2026

28 - 31 August 2026
Richmond Pharmacology is pleased to attend the ESC Congress 2026 in Munich, Germany, on 28 - 31 August 2026.
View event